리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 179 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 방사선량 관리 시장은 2030년까지 8억 3,520만 달러에 달할 전망
2023년에 3억 4,110만 달러로 평가된 세계의 방사선량 관리 시장은 2030년에는 8억 3,520만 달러에 이를 전망이며, 분석 기간 2023년부터 2030년까지 CAGR은 13.6%로 성장할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 방사선량 관리 솔루션은 CAGR 14.0%로 성장을 지속하고, 분석 기간 종료 시 4억 7,960만 달러에 달할 것으로 예측됩니다. 방사선량 관리 서비스 분야의 성장률은 분석 기간 동안 CAGR 13.2%로 추정됩니다.
미국 시장은 9,200만 달러로 추정, 중국은 CAGR 12.7%로 성장할 것으로 예측
미국의 방사선량 관리 시장은 2023년 9,200만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 분석 기간 2023년부터 2030년까지 CAGR 12.7%로 성장을 지속할 전망이며, 2030년까지 1억 2,630만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 12.3%와 11.3%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 9.8%로 성장할 것으로 예측됩니다.
세계의 방사선량 관리 시장-주요 동향 및 촉진요인 정리
방사선량 관리 : 의료 영상 진단에서 환자의 안전 확보
방사선량 관리란 X선, CT 스캔, 핵의학 등의 의료 영상처리에서 환자가 받는 방사선피폭량을 감시, 관리, 최적화하는 체계적인 접근법을 말합니다. 이 과정은 정확한 의학적 평가에 필요한 진단의 질을 달성하면서 환자의 안전을 보장하는 데 매우 중요합니다. 과도한 방사선피폭은 암 등 건강에 악영향을 미칠 위험을 높일 수 있으며 진단 정보의 무결성을 유지하면서 피폭을 최소화하는 것이 필수적입니다. 방사선량 관리 시스템은 방사선량을 추적하고 의료 종사자에게 과도한 노출 가능성을 경고하며 방사선 사용을 최적화하기 위한 모범 사례를 구현하도록 설계되었습니다. 이러한 시스템의 도입은 이미징의 이용이 세계적으로 증가하고 있는 가운데 점점 더 중요해지고 있습니다.
기술의 진보는 방사선량 관리를 어떻게 향상시키고 있는가?
기술의 진보로 방사선량 관리 시스템은 상당히 개선되었으며, 보다 효율적이고 정확하며 건강 관리 워크플로우에 통합되었습니다. 최신 시스템에는 방사선량 데이터를 실시간으로 분석하는 고급 분석 및 머신러닝 알고리즘이 내장되어 있어 의료 제공업체에게 즉각적인 피드백을 제공합니다. 이러한 시스템은 환자의 체격, 연령 및 특정 진단 요구 사항에 따라 촬영 프로토콜을 자동으로 조정할 수 있으므로 화질을 손상시키지 않고 불필요한 노출을 최소화할 수 있습니다. 방사선량 관리 시스템과 전자 의료 기록(EHR)을 통합함으로써 환자의 방사선 이력을 원활하게 기록 및 추적할 수 있어 향후 영상 진단에 대해 보다 개별화된 정보에 기초한 판단이 가능 됩니다. 또한, 선량 최적화 소프트웨어의 진보는 서로 다른 촬영 장비간에 프로토콜을 표준화할 수 있게 되어 건강 관리 시설 전반에서 방사선 관리의 일관성을 보장합니다. 이러한 기술적 개선은 첨단 방사선량 관리 시스템의 도입을 촉진하고, 환자의 안전성을 향상시키고, 의료 영상 진단의 치료 성적을 향상시킵니다.
의료 화상 진단에 있어서의 방사선량 관리의 주된 용도 및 이점이란?
방사선량 관리 시스템은 다양한 영상 진단 양식으로 활용되어 환자의 안전성, 규제 기준 준수, 건강 관리의 전반적인 품질을 향상시키는 수많은 이점을 제공합니다. 방사선 진단은 다른 이미징 기술에 비해 방사선량이 상대적으로 높은 것으로 알려진 CT 스캔 시 방사선 노출을 모니터링하고 줄이는 데 도움이 됩니다. 장기간의 노출을 수반하는 인터벤셔널 라디올로지에서 방사선량 관리는 환자와 의료진을 과도한 방사선으로부터 보호하기 위해 필수적입니다. 또, 소아는 방사선에 대한 감수성이 높기 때문에 방사선 피폭을 최소한으로 억제하는 것이 특히 중요한 소아 영상 진단에 있어서도, 방사선량 관리는 위력을 발휘합니다. 또한 방사선량 관리 시스템은 국제원자력기구(IAEA)와 유럽원자력공동체(Euratom)와 같은 국제적 기준과 규제 준수를 지원하여 의료 제공업체가 안전 요건을 충족할 수 있도록 보증합니다. 방사선량 관리의 주요 이점은 환자의 안전성 향상, 임상적 의사결정 개선, 방사선 유발성 합병증의 위험 감소 등으로 현대 의료 영상 진단에 필수적인 요소입니다.
방사선량 관리 시장의 성장을 가속하는 요인은?
방사선량 관리 시장의 성장은 여러 요인들에 의해 견인되고 있습니다. 의료 종사자와 환자 사이에서 방사선 안전에 대한 의식이 높아지고 있어 의료 화상 촬영시의 방사선 피폭을 최소화하는 것에 중점을 두고 있는 것이 큰 촉진요인이 되고 있습니다. 또한 선량 관리 소프트웨어, 데이터 분석, 머신러닝 등의 기술 진보도 이러한 시스템의 정확성과 효율성을 향상시켜 시장 성장을 가속하고 있습니다. 특히 고령화 사회에서 세계 영상 진단 건수 증가는 방사선량 관리 솔루션 수요를 더욱 밀어 올리고 있습니다. 또한 방사선 안전에 대한 엄격한 규제 요건과 인증 기준이 시장 성장에 기여하고 있습니다. 의료 서비스 제공업체는 고급 선량 관리 시스템을 도입하여 이러한 규정을 준수하려고 하기 때문입니다. 또한 전자기술(EHR)의 보급이 진행되고 방사선량 관리 시스템이 EHR에 통합되게 된 것도 시장 확대를 뒷받침하고 있습니다. 이러한 요인은 의료 기술의 지속적인 혁신과 함께 방사선량 관리 시장의 지속적인 성장을 뒷받침하고 있습니다.
조사 대상 기업 예(전 11건)
Agfa HealthCare
Bayer AG
Bracco Imaging SpA
FUJIFILM Holdings Corporation
GE Healthcare
Medsquare
Novarad Corporation
PACSHealth LLC
Philips Healthcare
Qaelum NV
Sectra AB
Siemens Healthineers
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향 및 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
AJY
영문 목차
영문목차
Global Radiation Dose Management Market to Reach US$835.2 Million by 2030
The global market for Radiation Dose Management estimated at US$341.1 Million in the year 2023, is expected to reach US$835.2 Million by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030. Radiation Dose Management Solutions, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$479.6 Million by the end of the analysis period. Growth in the Radiation Dose Management Services segment is estimated at 13.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$92.0 Million While China is Forecast to Grow at 12.7% CAGR
The Radiation Dose Management market in the U.S. is estimated at US$92.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$126.3 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.
Global Radiation Dose Management Market - Key Trends and Drivers Summarized
Radiation Dose Management: Ensuring Patient Safety in Medical Imaging
Radiation dose management refers to the systematic approach to monitoring, controlling, and optimizing the amount of radiation exposure patients receive during medical imaging procedures such as X-rays, CT scans, and nuclear medicine. This process is crucial in ensuring patient safety while achieving the diagnostic quality necessary for accurate medical evaluations. Excessive radiation exposure can increase the risk of adverse health effects, including cancer, making it essential to minimize exposure while maintaining the integrity of the diagnostic information. Radiation dose management systems are designed to track radiation doses, alert healthcare providers to potentially excessive exposure levels, and implement best practices to optimize radiation use. The implementation of these systems is becoming increasingly important as the use of diagnostic imaging continues to grow worldwide.
How Are Technological Advancements Enhancing Radiation Dose Management?
Technological advancements have significantly improved radiation dose management systems, making them more efficient, precise, and integrated into healthcare workflows. Modern systems now incorporate advanced analytics and machine learning algorithms that analyze radiation dose data in real-time, providing immediate feedback to healthcare providers. These systems can automatically adjust imaging protocols based on patient size, age, and the specific diagnostic requirement, thereby minimizing unnecessary exposure without compromising image quality. The integration of radiation dose management systems with electronic health records (EHRs) allows for seamless documentation and tracking of patient radiation histories, enabling more personalized and informed decisions about future imaging procedures. Additionally, advancements in dose optimization software have made it possible to standardize protocols across different imaging devices, ensuring consistency in radiation management across a healthcare facility. These technological improvements are driving the adoption of sophisticated radiation dose management systems, enhancing patient safety and improving outcomes in medical imaging.
What Are the Key Applications and Benefits of Radiation Dose Management in Medical Imaging?
Radiation dose management systems are utilized across various imaging modalities, offering numerous benefits that enhance patient safety, compliance with regulatory standards, and overall healthcare quality. In diagnostic radiology, these systems help monitor and reduce radiation exposure during CT scans, which are known for their relatively high radiation doses compared to other imaging techniques. In interventional radiology, where procedures often involve prolonged exposure times, radiation dose management is critical for protecting both patients and healthcare staff from excessive radiation. The systems are also valuable in pediatric imaging, where minimizing radiation exposure is particularly important due to the increased sensitivity of children to radiation. Furthermore, radiation dose management systems support compliance with international standards and regulations, such as those set by the International Atomic Energy Agency (IAEA) and the European Atomic Energy Community (Euratom), ensuring that healthcare providers meet safety requirements. The primary benefits of radiation dose management include enhanced patient safety, improved clinical decision-making, and reduced risk of radiation-induced complications, making it an essential component of modern medical imaging practices.
What Factors Are Driving the Growth in the Radiation Dose Management Market?
The growth in the Radiation Dose Management market is driven by several factors. The increasing awareness of radiation safety among healthcare providers and patients is a significant driver, as more emphasis is placed on minimizing radiation exposure during medical imaging. Technological advancements in dose management software, data analytics, and machine learning are also propelling market growth by improving the precision and efficiency of these systems. The rising number of diagnostic imaging procedures worldwide, particularly in aging populations, is further boosting demand for radiation dose management solutions, as these systems are essential for ensuring patient safety in high-volume imaging environments. Additionally, stringent regulatory requirements and accreditation standards related to radiation safety are contributing to market growth, as healthcare providers seek to comply with these regulations by implementing advanced dose management systems. The growing adoption of electronic health records (EHRs) and the integration of dose management systems with EHRs are also supporting market expansion, as these technologies enable better tracking and optimization of radiation exposure. These factors, combined with continuous innovation in healthcare technology, are driving the sustained growth of the Radiation Dose Management market.
Select Competitors (Total 11 Featured) -
Agfa HealthCare
Bayer AG
Bracco Imaging SpA
FUJIFILM Holdings Corporation
GE Healthcare
Medsquare
Novarad Corporation
PACSHealth LLC
Philips Healthcare
Qaelum N.V.
Sectra AB
Siemens Healthineers
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Radiation Dose Management - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Focus on Patient Safety and Radiation Protection Propels Market Growth
Technological Advancements in Dose Tracking and Monitoring Software Strengthen Market Position
Growing Adoption of Digital Health Records Drives Integration of Dose Management Systems
Surge in Demand for Dose Management Solutions in Diagnostic Imaging Generates New Opportunities
Development of AI and Machine Learning-Based Dose Optimization Sustains Market Growth
Expanding Applications in Interventional Radiology Throws Spotlight on Market Potential
Growth in Radiology Practices and Imaging Centers Spurs Demand for Dose Management
Increasing Awareness of Radiation-Induced Health Risks Strengthens Business Case
Rising Adoption of Cloud-Based Dose Management Solutions Propels Market Expansion
Surge in Demand for Automated Dose Monitoring in Radiation Therapy Expands Market Horizons
Growing Emphasis on Compliance with International Radiation Safety Standards Drives Market Adoption
Innovations in Real-Time Dose Monitoring and Reporting Generate New Market Opportunities
Rising Demand for Dose Management in Pediatric and Geriatric Imaging Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World 7-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Radiography & Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 4: World 7-Year Perspective for Radiography & Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World 7-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 9: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 10: World 7-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 11: World Radiation Dose Management Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 12: World Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 13: World 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World 7-Year Perspective for Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Fluoroscopy & Interventional Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 19: World 7-Year Perspective for Fluoroscopy & Interventional Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 22: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 23: USA 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 24: USA Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 25: USA 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
CANADA
TABLE 28: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 29: Canada 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 30: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 31: Canada 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
JAPAN
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 34: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 35: Japan 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 36: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 37: Japan 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
CHINA
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 40: China Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 41: China 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 42: China Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 43: China 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
EUROPE
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 46: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 47: Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 48: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 49: Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 51: Europe 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
TABLE 52: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 53: Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
FRANCE
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 54: France Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 55: France 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 58: France Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 59: France 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
GERMANY
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 60: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 61: Germany 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 64: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 65: Germany 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
ITALY
TABLE 66: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 67: Italy 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 70: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 71: Italy 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
UNITED KINGDOM
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 72: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 73: UK 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 76: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 77: UK 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
REST OF EUROPE
TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 79: Rest of Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Rest of Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 83: Rest of Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
ASIA-PACIFIC
Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 85: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Asia-Pacific 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 89: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
REST OF WORLD
TABLE 90: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 91: Rest of World 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of World 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
TABLE 94: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 95: Rest of World 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030